To characterize the ecological effects of biologic therapies on the gut bacterial and fungal microbiome of psoriatic arthritis (PsA)/spondyloarthritis (SpA) patients.
Manasson, J., Wallach, D.S., Guggino, G., Stapylton, M., Badri, M.H., Solomon, G., et al. (2020). IL-17 Inhibition in Spondyloarthritis Associates with Subclinical Gut Microbiome Perturbations and a Distinctive IL-25-Driven Intestinal Inflammation. ARTHRITIS & RHEUMATOLOGY [10.1002/art.41169].
IL-17 Inhibition in Spondyloarthritis Associates with Subclinical Gut Microbiome Perturbations and a Distinctive IL-25-Driven Intestinal Inflammation
Guggino, GiulianaMembro del Collaboration Group
;Ciccia, FrancescoMembro del Collaboration Group
;
2020-01-01
Abstract
To characterize the ecological effects of biologic therapies on the gut bacterial and fungal microbiome of psoriatic arthritis (PsA)/spondyloarthritis (SpA) patients.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
manasson (1).pdf
Solo gestori archvio
Tipologia:
Post-print
Dimensione
1.54 MB
Formato
Adobe PDF
|
1.54 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
